References
- Wegener M, Neuhausen P, Börsch G, Ricken D. Significance of serum immunoglobulins for the diagnosis of alcohol-induced liver diseases. Dtsch Med Wochenschr. 1986; 111: 1716–20.
- Maruyama S, Hirayama C, Horie Y, Yorozu K, Maeda K, Inoue M, et al.. Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome. Hepatogastroenterology. 2007; 54: 493–8.
- Watt K, Uhanova J, Gong Y, Kaita K, Doucette K, Pettigrew N, et al.. Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat. 2004; 11: 251–6.
- Tanaka S, Okamoto Y, Yamazaki M, Mitani N, Nakqjima Y, Fukui H. Significance of hyperglobulinemia in severe chronic liver diseases – with special reference to the correlation between serum globulin/IgG level and ICG clearance. Hepatogastroenterology. 2007; 54: 2301–5.
- Czaja AJ. Diagnosis and therapy of autoimmune liver disease. Med Clin North Am. 1996; 80: 973–94.
- Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al.. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31: 929–38.
- Bogdanos D, Invernizzi P, Mackay I, Vergani D. Autoimmune liver serology current diagnostic and clinical challenge. World J Gastroenterol. 2008; 14: 3374–87.
- Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al.. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008; 48: 169–76.
- Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993. Oct;18(4): 998–1005.
- Czaja1 A, Freese D. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002; 36: 479–97.
- Gonzàlez-Quintela A, Alende MR, Gamallo R, Gonzàlez-Gil P, López-Ben S, Tomé S, et al.. Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non-cirrhotic alcoholic liver disease. Hepatogastroenterology. 2003; 50: 2121–6.
- El-Kady IM. Assessment of humoral immune response in patients with chronic hepatitis C virus infection. Egypt J Immunol. 2004; 11: 141–7.
- Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Hepatogastroenterology. 1997; 44: 417–25.
- Ghonaim M, Al-Ghamdi A, El-Bana H, Bakr A, Ghoneim E, El-Edel R, et al.. Autoantibodies in chronic liver disease. Egypt J Immunol. 2005; 12: 101–11.